The Development of PROQOL-HIV: An International Instrument to Assess the Health-Related Quality of Life of Persons Living With HIV/AIDS

Objectives:Health-related quality of life (HRQL) is an important outcome in HIV/AIDS infection and treatment. However, most existing HIV-HRQL instruments miss important issues (eg, sleeping problems, lipodystrophy). They were developed before highly active antiretroviral therapy (pre-HAART), and in a single language. We sought to develop a contemporary HIV-HRQL instrument (PROQOL-HIV) in multiple languages that accounts for HAART treatment and side effects. This article details the 3-stage content validation phase of PROQOL-HIV. Methods:In stage 1, we developed a conceptual model of HIV-HRQL and questionnaire item bank from thematic analysis of 152 patient interviews conducted simultaneously across 9 countries. In stage 2, pilot items were selected by an expert panel to form the pilot instrument. Stage 3 involved linguistic validation and harmonization of selected items to form an equivalent instrument in 9 target languages. Results:Analysis of 3375 pages of interview text revealed 11 underlying themes: general health perception, social relationships, emotions, energy/fatigue, sleep, cognitive functioning, physical and daily activity, coping, future, symptoms, and treatment. Seven issues new to HIV-HRQL measurement were subsumed by these themes: infection fears, future concerns, satisfaction with care, self-esteem problems, sleep problems, work disruption, and treatment issues. Of the 442 theme-related items banked, 70 items met the retention criteria and formed the pilot PROQOL-HIV instrument. Conclusions:HIV patients across 11 countries attributed a wide range of physical, mental, and social issues to their condition, many of which were not measured by existing HIV-HRQL instruments. The pilot PROQOL-HIV instrument captures these issues, is sensitive to sociocultural context, disease stage, and HAART.

[1]  P. Duncan,et al.  A further investigation of health-related quality of life over time among men with HIV infection in the HAART era , 2007, Quality of Life Research.

[2]  O. Chassany,et al.  Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory Process , 2002 .

[3]  A. Wu,et al.  Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV) , 1997, Quality of Life Research.

[4]  J. Shea,et al.  A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: development, reliability, and validity. , 1998, Medical care.

[5]  J. Walkup,et al.  Coping with AIDS: The Challenges of an Evolving Disease , 2007 .

[6]  D. Cella,et al.  Development and validation of the functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument , 1996, Quality of Life Research.

[7]  D. Bachani,et al.  Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region , 2010, AIDS.

[8]  G. Guyatt,et al.  PMI25: THE RELATION OF DISTRIBUTION-AND ANCHOR-BASED APPROACHES ON INTERPRETATION OF CHANGES IN HEALTH-RELATED QUALITY OF LIFE , 2001 .

[9]  S. Saxena,et al.  The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. , 1995, Social science & medicine.

[10]  N. Avis,et al.  Use of the MQoL-HIV with asymptomatic HIV-positive patients , 1997, Quality of Life Research.

[11]  D. Wild,et al.  A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials , 2012, PharmacoEconomics.

[12]  A. Wu,et al.  Quality of life assessment comes of age in the era of highly active antiretroviral therapy. , 2000, AIDS.

[13]  M. Patton,et al.  Qualitative evaluation and research methods , 1992 .

[14]  U. S. Department of Health and Human Services FDA Cen Research,et al.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance , 2006, Health and quality of life outcomes.

[15]  S. Skevington Initial steps to developing the World Health Organization's Quality of Life Instrument (WHOQOL) module for international assessment in HIV/AIDS , 2003, AIDS care.

[16]  Elizabeth Molsen,et al.  Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  P. Ganz,et al.  Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems—Evaluation System (HOPES) , 1993, Quality of Life Research.

[18]  D. Lubeck,et al.  Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time- Oriented Health Outcome Study (ATHOS) , 1997, Quality of Life Research.